Productivity costs before and after absence from work: as important as common?

被引:67
作者
Brouwer, WBF [1 ]
van Exel, NJA [1 ]
Koopmanschap, MA [1 ]
Rutten, FFH [1 ]
机构
[1] Erasmus Univ, Inst Med Technol Assessment, NL-3000 DR Rotterdam, Netherlands
关键词
productivity costs; economic evaluation; methodology;
D O I
10.1016/S0168-8510(01)00233-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Traditionally, production losses are estimated using the human capital or friction cost method. These methods base estimations of productivity costs on data on absence from work. For some diseases, like migraine, productivity losses without absence are occasionally calculated by estimating the production losses from reduced productivity at work. However, diseases typically only associated with absence may also be expected to cause reduced productivity before and after absence. In a previous study, Brouwer et al. [4] concluded that productivity losses without absence are also very relevant in common diseases, like influenza, common cold or neck-problems. Studying a new sample of employees of a Dutch trade-firm (n = 5 1), who completed the questionnaire 'Ill and Recovered' upon return to work after absence due to illness, it was revealed that about 25% of the respondents experienced production losses before absence and about 20% of the respondents experience production losses after absence. This leads to an increase in estimated production losses of about 16% compared with only considering absence data. Current productivity costs estimates based solely on absence data may, therefore, underestimate real productivity costs. Compensation mechanisms in firms may reduce the underestimation. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:173 / 187
页数:15
相关论文
共 20 条
  • [1] Brouwer WBF, 1997, HEALTH ECON, V6, P253, DOI 10.1002/(SICI)1099-1050(199705)6:3<253::AID-HEC266>3.3.CO
  • [2] 2-Y
  • [3] Brouwer WBF, 1997, HEALTH ECON, V6, P511, DOI 10.1002/(SICI)1099-1050(199709)6:5<511::AID-HEC297>3.0.CO
  • [4] 2-K
  • [5] Productivity losses without absence: measurement validation and empirical evidence
    Brouwer, WBF
    Koopmanschap, MA
    Rutten, FFH
    [J]. HEALTH POLICY, 1999, 48 (01) : 13 - 27
  • [6] Patient and informal caregiver time in cost-effectiveness analysis - A response to the recommendations of the Washington panel
    Brouwer, WBF
    Koopmanschap, MA
    Rutten, FFH
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1998, 14 (03) : 505 - 513
  • [7] On the economic foundations of CEA. Ladies and gentlemen, take your positions!
    Brouwer, WBF
    Koopmanschap, MA
    [J]. JOURNAL OF HEALTH ECONOMICS, 2000, 19 (04) : 439 - 459
  • [8] Drummond M., 2015, METHODS EC EVALUATIO, V4
  • [9] DRUMMOND MF, 1991, 88 U YORK CTR HLTH E
  • [10] Gold MR, 1996, COST EFFECTIVENESS H